Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 9
2008 5
2009 6
2010 3
2011 1
2012 4
2013 6
2014 2
2015 4
2016 4
2017 6
2018 4
2020 2
2021 2
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlmüller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Grüner R, Eidelberg D, Tzoulis C. Brakedal B, et al. Among authors: haugarvoll k. Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. Cell Metab. 2022. PMID: 35235774 Free article. Clinical Trial.
PARK8 LRRK2 parkinsonism.
Haugarvoll K, Wszolek ZK. Haugarvoll K, et al. Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0. Curr Neurol Neurosci Rep. 2006. PMID: 16822348 Review.
Nigrostriatal denervation sine parkinsonism.
Haugarvoll K, Bindoff LA, Tzoulis C. Haugarvoll K, et al. Brain. 2016 Apr;139(Pt 4):e25. doi: 10.1093/brain/awv410. Epub 2016 Jan 25. Brain. 2016. PMID: 26811251 No abstract available.
Clinical features of LRRK2 parkinsonism.
Haugarvoll K, Wszolek ZK. Haugarvoll K, et al. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S205-8. doi: 10.1016/S1353-8020(09)70815-6. Parkinsonism Relat Disord. 2009. PMID: 20082991 Review.
The genetics of frontotemporal dementia.
Haugarvoll K, Wszolek ZK, Hutton M. Haugarvoll K, et al. Neurol Clin. 2007 Aug;25(3):697-715, vi. doi: 10.1016/j.ncl.2007.03.002. Neurol Clin. 2007. PMID: 17659186 Review.
The STRAT-PARK cohort: a personalized initiative to stratify Parkinson's disease.
Stige KE, Kverneng SU, Sharma S, Skeie GO, Sheard E, Søgnen M, Geijerstam SA, Vetås T, Wahlvåg AG, Berven H, Buch S, Reese D, Babiker D, Mahdi Y, Wade T, Miranda GP, Ganguly J, Tamilselvam YK, Chai JR, Bansal S, Aur D, Soltani S, Adams S, Dölle C, Dick F, Berntsen EM, Grüner R, Brekke N, Riemer F, Goa PE, Haugarvoll K, Haacke EM, Jog M, Tzoulis C. Stige KE, et al. Among authors: haugarvoll k. Prog Neurobiol. 2024 Apr 9:102603. doi: 10.1016/j.pneurobio.2024.102603. Online ahead of print. Prog Neurobiol. 2024. PMID: 38604582 Free article. Review.
Phactr2 and Parkinson's disease.
Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Wider C, et al. Among authors: haugarvoll k. Neurosci Lett. 2009 Mar 27;453(1):9-11. doi: 10.1016/j.neulet.2009.02.009. Epub 2009 Feb 10. Neurosci Lett. 2009. PMID: 19429005 Free PMC article.
Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease.
Nido GS, Dölle C, Flønes I, Tuppen HA, Alves G, Tysnes OB, Haugarvoll K, Tzoulis C. Nido GS, et al. Among authors: haugarvoll k. Neurobiol Aging. 2018 Mar;63:120-127. doi: 10.1016/j.neurobiolaging.2017.10.024. Epub 2017 Dec 8. Neurobiol Aging. 2018. PMID: 29257976 Free article.
59 results